Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,385 public trials 2,846 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy

NCT06941870

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Orthopedic Institute for Children- Site Number : 8400009 Los Angeles, California, United States
  • Innovative Hematology, Inc.- Site Number : 8400006 Indianapolis, Indiana, United States
  • University of Iowa- Site Number : 8400004 Iowa City, Iowa, United States
  • Ohio State University Hospital East- Site Number : 8400001 Columbus, Ohio, United States
View all 13 locations
View Trial Details
Recruiting

An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B

NCT06700096

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Chelyabinsk Regional Clinical Hospital Chelyabinsk, Russia
  • Federal State Budgetary Organization of Science "Kirov Research Institute of Hematology and Blood Transfusions of Federal Medical Biological agency" Kirov, Russia
  • Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Clinical Diagnostics for Hematology and Hemostasis Disorders) Moscow, Russia
  • Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Traumatology and Reconstructive and Restorative Orthopedics for Patients with Hemophilia) Moscow, Russia
View all 14 locations
View Trial Details
Recruiting

Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET

NCT06552429

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Peking Union Hospital, Chinese Academy of Medical Sciences Beijing, China
  • Peking University People's Hospital Beijing, China
  • Union Hospital affiliated to Fujian Medical University Fujian, China
  • Nanfang Hospital, Southern Medical University Guangzhou, China
View Trial Details
Recruiting

Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML

NCT06451861

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Dongguan General Hosptial Dongguan, Guangdong, China
  • Foshan First People's Hospital Foshan, Guangdong, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View all 13 locations
View Trial Details
Recruiting

Integrative Training Program for Pediatric Sickle Cell Pain

NCT06691867

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Arthur M. Blank Hospital | Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

NCT05643742

Conditions
B-cell Lymphoma, B-cell Malignancy, Chronic Disease, +27 more
Locations
  • University of Kansas Westwood, Kansas, United States
  • Washington University St Louis, Missouri, United States
  • SCRI San Antonio, Texas, United States
  • University of Utah Salt Lake City, Utah, United States
View Trial Details

Related conditions